In Brief: Fuisz Technologies
This article was originally published in The Tan Sheet
Executive Summary
Fuisz Technologies: Enters into agreement with Bayer Consumer Care Division for development of an undisclosed OTC drug "using one of Fuisz' proprietary rapid dissolve dosage forms." The company also is developing an EZ Chew version of an undisclosed SmithKline Beecham OTC product ("The Tan Sheet" Aug. 5, In Brief) and has a long-standing agreement with Whitehall-Robins for a "major" OTC ("The Tan Sheet" Aug. 19, p. 7)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning